Cargando…
Biochemical evaluation of bone turnover in cancer patients with bone metastases: relationship with radiograph appearances and disease extension.
Serum bone alkaline phosphatase (BALP), serum carboxy-terminal propeptide of type I procollagen (PICP) and serum bone gla protein (BGP) as markers of bone formation, serum carboxy-terminal telopeptide of type I collagen (ICTP) as a marker of collagen resorption and fasting molar ratio of urinary cal...
Autores principales: | Berruti, A., Piovesan, A., Torta, M., Raucci, C. A., Gorzegno, G., Paccotti, P., Dogliotti, L., Angeli, A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074561/ https://www.ncbi.nlm.nih.gov/pubmed/8664134 |
Ejemplares similares
-
Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases
por: Generali, D, et al.
Publicado: (2008) -
Predictive factors for skeletal complications in hormone-refractory prostate cancer patients with metastatic bone disease
por: Berruti, A, et al.
Publicado: (2005) -
Relationship between CA 15-3 serum levels and disease extent in predicting overall survival of breast cancer patients with newly diagnosed metastatic disease.
por: Tampellini, M., et al.
Publicado: (1997) -
Biochemical markers of bone turnover and their association with bone marrow lesions
por: Hunter, David J, et al.
Publicado: (2008) -
Diabetes, Biochemical Markers of Bone Turnover, Diabetes Control, and Bone
por: Starup-Linde, Jakob
Publicado: (2013)